CLINICAL_TRIALS
trial_result
· 2017-06-26
Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) [Phase 1]
Summary
Phase 1 study of pembrolizumab (MK-3475) in advanced solid tumors has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Cancer, Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2017-06-26